Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DRIP: Remimazolam ED50 for Pediatric Intubation
NCT06170918Not yet recruiting
- Start
- Dec 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of remimazolam in general anesthesia. Primary endpoints: Half effective dose for intubation at 5 minutes and Cardiovascular response to tracheal intubation at 8 minutes. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT06170918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06170918.